Patents-Review.com
ClassID:

21158 ⎘

A61K39/44 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum Antibodies bound to carriers

Recent Application in this class:
#1
20260132383
2026-05-14

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

 #2
20260116954
2026-04-30

CHIMERIC PROTEIN COMPRISING AN ANTI-INFLUENZA VIRUS ANTIBODY MOIETY AND A MUCOADHESIVE PEPTIDE FRAGMENT FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

 #3
20250387480
2025-12-25

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #4
20250302763
2025-10-02

IMMUNE ENGINEERING AMPLIFICATION

 #5
20250186585
2025-06-12

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

 #6
20250177523
2025-06-05

MULTISPECIFIC ANTIGEN-BINDING PROTEINS

 #7
20250049942
2025-02-13

NUCLEIC ACID CARRIERS AND THERAPEUTIC METHODS OF USE

 #8
20250034235
2025-01-30

COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

 #9
20250032610
2025-01-30

MULTISPECIFIC ANTIGEN-BINDING PROTEINS

 #10
20240269291
2024-08-15

Transcutol-Polyol-Active Agent Ternary Complex, Pharmaceutical Composition for Topical Use Comprising Same, Method for Obtaining Same and Use Thereof in Different Pathologies

 #11
20240261447
2024-08-08

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION

 #12
20240148865
2024-05-09

Induction of IL-12 using immunotherapy

 #13
20240122984
2024-04-18

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

 #14
20240091353
2024-03-21

Compositions and methods for immunotherapy

 #15
20230364232
2023-11-16

IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERS

 #16
20220409725
2022-12-29

Multispecific antigen-binding proteins

 #17
20220118089
2022-04-21

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #18
20220096632
2022-03-31

HIV-1 neutralizing antibodies and uses thereof

 #19
20210347816
2021-11-11

METHOD FOR AFFINITY PURIFICATION

 #20
20210346504
2021-11-11

Exosomes For Delivery Of Biotherapeutics

 #21
20210330804
2021-10-28

CELL PENETRATING CONJUGATES AND METHODS OF USE THEREOF

 #22
20210317231
2021-10-14

Anti-5T4 antibodies and antibody-drug conjugates

 #23
20210268106
2021-09-02

Induction of IL-12 using immunotherapy

 #24
20210162064
2021-06-03

Nucleic acid carriers and therapeutic methods of use

 #25
20210084962
2021-03-25

Coated egg yolk cores, methods of making and methods of use thereof

 #26
20210023217
2021-01-28

PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT

 #27
20210015863
2021-01-21

Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse

 #28
20200345855
2020-11-05

Compositions and methods for immunotherapy

 #29
20200345854
2020-11-05

BISPECIFIC ANTIBODY CAPABLE OF BEING COMBINED WITH IMMUNE CELLS TO ENHANCE TUMOR KILLING CAPABILITY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

 #30
20200317781
2020-10-08

Compositions and methods for immunotherapy

 #31
20200276131
2020-09-03

Methods for targeted delivery of agents to degraded elastic fibers

 #32
20200150113
2020-05-14

Method of storing latex particle dispersion liquid

 #33
20200095546
2020-03-26

Nanoscale artificial antigen presenting cells

 #34
20200023083
2020-01-23

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

 #35
20200009053
2020-01-09

Materials and methods for delivering compositions to selected tissues

 #36
20190249163
2019-08-15

Delivery of therapeutic agents by a collagen binding protein

 #37
20190194346
2019-06-27

Anti-5T4 antibodies and antibody-drug conjugates

 #38
20190142966
2019-05-16

Functionalized Nanoparticles and Compositions for Cancer Treatment and Methods

 #39
20190055299
2019-02-21

Chimeric antigen receptor molecules and uses thereof

 #40
20190054121
2019-02-21

Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse

 #41
20190046572
2019-02-14

Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse

 #42
20190045830
2019-02-14

Coated egg yolk cores, methods of making and methods of use thereof

 #43
20180319875
2018-11-08

Anti-nodal antibodies and methods of using same

 #44
20180298090
2018-10-18

Anti-nodal antibodies and methods of using same

 #45
20180256719
2018-09-13

HIV-1 neutralizing antibodies and uses thereof

 #46
20180221483
2018-08-09

TIMED RELEASE OF SUBSTANCES TO TREAT OCULAR DISORDERS

 #47
20180214564
2018-08-02

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

 #48
20180193456
2018-07-12

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) ANTIBODIES

 #49
20180185501
2018-07-05

Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same

 #50
20180177873
2018-06-28

Multispecific antigen-binding proteins

 #51
20180154016
2018-06-07

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #52
20180147289
2018-05-31

Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers

 #53
20180133316
2018-05-17

Conjugates of CC-1065 analogs and bifunctional linkers

 #54
20180125994
2018-05-10

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES

 #55
20180117172
2018-05-03

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES

 #56
20180028684
2018-02-01

TARGETED NANOPARTICLES

 #57
20180021440
2018-01-25

Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof

 #58
20170369527
2017-12-28

METHOD FOR AFFINITY PURIFICATION

 #59
20170355733
2017-12-14

Modified Fab region-binding peptide

 #60
20170333567
2017-11-23

Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers

 #61
20170333365
2017-11-23

CORE-SHELL PARTICLE FORMULATION FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS

 #62
20170326235
2017-11-16

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

 #63
20170320966
2017-11-09

Humanized monoclonal antibody and uses thereof

 #64
20170274090
2017-09-28

Conjugates of CC-1065 analogs and bifunctional linkers

 #65
20170266276
2017-09-21

Combination Therapy For Treatment of Cancer

 #66
20170232099
2017-08-17

Therapy-enhancing glucan

 #67
20170209592
2017-07-27

Formation of delivery agents targeted to degraded elastic fibers

 #68
20170204390
2017-07-20

Delivery of therapeutic agents by a collagen binding protein

 #69
20170196975
2017-07-13

Conjugates of an anti-TNF-alpha antibody

 #70
20170089922
2017-03-30

Methods and compositions for wound treatment

 #71
20170056521
2017-03-02

Fusion protein for treating rejection reaction in transplantation

 #72
20170056520
2017-03-02

Multi-arm linker for treating rejection reaction in transplantation

 #73
20170007706
2017-01-12

Sialic acid derivatives for protein derivatisation and conjugation

 #74
20160367671
2016-12-22

Nanoparticle Composition for Use in Targeting Cancer Stem Cells and Method for Treatment of Cancer

 #75
20160363597
2016-12-15

Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof

 #76
20160338960
2016-11-24

Materials and methods for delivering compositions to selected tissues

 #77
20160317671
2016-11-03

Cell penetrating conjugates and methods of use thereof

 #78
20160304592
2016-10-20

SPARC binding ScFvs

 #79
20160287714
2016-10-06

Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same

 #80
20160184450
2016-06-30

DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #81
20160129133
2016-05-12

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

 #82
20160120977
2016-05-05

Proteins modified with (amino) monosaccharide-biotin adduct

 #83
20160114053
2016-04-28

Methods and compositions for delivering active agents with enhanced pharmacological properties

 #84
20160106858
2016-04-21

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

 #85
20160106852
2016-04-21

Targeted therapeutic nanoparticles

 #86
20160089433
2016-03-31

Allogeneic T-cell compositions for induction of IL-12

 #87
20160082113
2016-03-24

ALTERING A B CELL PATHOLOGY USING SELF-DERIVED ANTIGENS IN CONJUNCTION WITH SPECIFIC-BINDING CYTOREDUCTIVE AGENT

 #88
20160051698
2016-02-25

Nanoscale artificial antigen presenting cells

 #89
20160039906
2016-02-11

METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRANSPLANT REJECTION

 #90
20160039905
2016-02-11

B7-H4 fusion proteins and methods of use thereof

 #91
20160031988
2016-02-04

MULTIVARIABLE ANTIGENS COMPLEXED WITH TARGETING HUMANIZED MONOCLONAL ANTIBODY

 #92
20160030587
2016-02-04

Conjugates of an anti-TNF-alpha antibody

 #93
20160008399
2016-01-14

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

 #94
20150368261
2015-12-24

CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR

 #95
20150306212
2015-10-29

Synthetic membrane-receiver complexes

 #96
20150297740
2015-10-22

VEGF neutralizing prodrugs for the treatment of ocular conditions

 #97
20150290333
2015-10-15

PROCESS AND MATERIALS FOR MEDICAL APPLICATIONS

 #98
20150209288
2015-07-30

Core-shell particle formulation for delivering multiple therapeutic agents

 #99
20150182588
2015-07-02

SYNTHETIC MEMBRANE-RECEIVER COMPLEXES

 #100
20150175711
2015-06-25

Anti-CD22 anti-idiotypic antibodies and uses thereof

 #101
20150174266
2015-06-25

APROTININ POLYPEPTIDES FOR TRANSPORTING A COMPOUND ACROSS THE BLOOD-BRAIN BARRIER

 #102
20150118256
2015-04-30

IgE CH3 peptide vaccine

 #103
20150098897
2015-04-09

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

 #104
20150079115
2015-03-19

Compositions and methods for preventing or relieving symptoms of infections

 #105
20150071997
2015-03-12

Microgels for encapsulation of cells and other biologic agents

 #106
20150071989
2015-03-12

LIPOSOMES FOR HEMATOLOGICAL TUMORS

 #107
20150056218
2015-02-26

P97 fragments with transfer activity

 #108
20140377215
2014-12-25

Delivery of therapeutic agents by a collagen binding protein

 #109
20140370016
2014-12-18

SPARC binding ScFcs

 #110
20140356382
2014-12-04

Exosomes for delivery of biotherapeutics

 #111
20140341905
2014-11-20

SPARC binding ScFcs

 #112
20140341904
2014-11-20

SPARC binding ScFvs

 #113
20140335100
2014-11-13

Therapy-enhancing glucan

 #114
20140314665
2014-10-23

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

 #115
20140294723
2014-10-02

Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart

 #116
20140275509
2014-09-18

MULTIFUNCTIONALIZED MATERIALS

 #117
20140220133
2014-08-07

Nanotechnology Based Medicine for Biodefense

 #118
20140220045
2014-08-07

Compositions of a peptide targeting system for treating cancer

 #119
20140205995
2014-07-24

Molecular conjugate

 #120
20140199376
2014-07-17

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

 #121
20140199232
2014-07-17

Targeted therapeutic nanoparticles

 #122
20140134192
2014-05-15

Methods and compositions for wound treatment

 #123
20140065145
2014-03-06

Method for producing solid formulations comprising immunoglobulin single variable domains

 #124
20140017263
2014-01-16

Delivery Agents for Targeted Treatment of Elastin Degradation

 #125
20140004185
2014-01-02

Pharmaceutical composition

 #126
20130315964
2013-11-28

PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITING OF PRODUCTION OR AMPLIFYING OF ELIMINATION OF P24 PROTEIN

 #127
20130315927
2013-11-28

PCSK9 ANTAGONISTS

 #128
20130315823
2013-11-28

SPARC binding peptides and uses thereof

 #129
20130280250
2013-10-24

Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy

 #130
20130245234
2013-09-19

Vmp-like sequences of pathogenic

#131
20130224759
2013-08-29

Methods, devices, kits and compositions for detecting roundworm

 #132
20130224227
2013-08-29

Conjugates of CC-1065 analogs and bifunctional linkers

 #133
20130183295
2013-07-18

Therapy-enhancing glucan

 #134
20130183249
2013-07-18

Stimulus Sensitive Magnetic Nanocomposite Using Pyrene Polymer, and Contrast Medium Composition Containing the Nanocomposite

 #135
20130101551
2013-04-25

Induction of IL-12 using immunotherapy

 #136
20130071392
2013-03-21

Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia

 #137
20130058873
2013-03-07

P97 fragments with transfer activity

 #138
20120276095
2012-11-01

B7-H4 fusion proteins and methods of use thereof

 #139
20120263726
2012-10-18

Pharmaceutical composition and method of inhibiting of production or amplifying of elimination of P24 protein

 #140
20120219560
2012-08-30

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #141
20120208742
2012-08-16

Compositions of a peptide targeting system for treating cancer

 #142
20120177645
2012-07-12

Methods and compositions for the inhibition of transplant rejection

 #143
20120156283
2012-06-21

Methods and compositions for wound treatment

 #144
20120156227
2012-06-21

PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT

 #145
20120122238
2012-05-17

VMP-like sequences of pathogenic

#146
20120082685
2012-04-05

Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy

 #147
20120039801
2012-02-16

SPARC binding peptides and uses thereof

 #148
20120014954
2012-01-19

SPARC binding ScFvs

 #149
20110300163
2011-12-08

IgE CH3 peptide vaccine

 #150
20110223146
2011-09-15

METHODS FOR PREPARATION AND USE OF MARROW INFILTRATNG LYMPHOCTYES (MILS)

 #151
20110200530
2011-08-18

Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same

 #152
20110195071
2011-08-11

Therapy-enhancing glucan

 #153
20110177153
2011-07-21

TARGETED NANOPARTICLE DRUG FOR MAGNETIC HYPERTHERMIA TREATMENT ON MALIGNANT TUMORS

 #154
20110171128
2011-07-14

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #155
20110105980
2011-05-05

Treatment of thromboangiitis obliterans by removal of autoantibodies

 #156
20110086340
2011-04-14

Methods, devices, kits and compositions for detecting roundworm

 #157
20110082077
2011-04-07

Sialic acid derivatives for protein derivatisation and conjugation

 #158
20100330115
2010-12-30

Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody

 #159
20100317026
2010-12-16

VMP-like sequences of pathogenic

#160
20100310454
2010-12-09

COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND /OR THEIR CANCEROUS COUNTERPART

 #161
20100273867
2010-10-28

THERAPY-ENHANCING GLUCAN

 #162
20100260762
2010-10-14

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

 #163
20100216743
2010-08-26

THERAPY-ENHANCING GLUCAN

 #164
20100196435
2010-08-05

MATERIALS AND METHODS FOR DELIVERING COMPOSITIONS TO SELECTED TISSUES

 #165
20100136652
2010-06-03

Molecular conjugate

 #166
20100021481
2010-01-28

Conjugates of an anti-TNF-α antibody

 #167
20090304684
2009-12-10

METHODS AND COMPOSITIONS FOR NEEDLELESS DELIVERY OF ANTIBODIES

 #168
20090202473
2009-08-13

Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart

 #169
20090035257
2009-02-05

Devices, compositions and methods for the protection and repair of cells and tissues

 #170
20080299039
2008-12-04

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #171
20080254044
2008-10-16

Multivariable antigens complexed with targeting humanized monoclonal antibody

 #172
20080249285
2008-10-09

Method For Affinity Purification

 #173
20080193456
2008-08-14

THERAPY-ENHANCING GLUCAN

 #174
20070191597
2007-08-16

Sialic acid derivatives for protein derivatisation and conjugation

 #175
20070172520
2007-07-26

Immunotargeting of Nonionic Surfactant Vesicles

 #176
20070148088
2007-06-28

Cytotoxic therapy

 #177
20070141070
2007-06-21

Compositions for needleless delivery of antibodies

 #178
20070117970
2007-05-24

VMP-like sequences of pathogenic

#179
20070117153
2007-05-24

Molecular conjugate

 #180
20060222595
2006-10-05

Nanoparticles for therapeutic and diagnostic applications

 #181
20060189515
2006-08-24

Molecules for transporting a compound across the blood-brain barrier

 #182
20060188506
2006-08-24

Therapy-enhancing glucan

 #183
20060160766
2006-07-20

Therapy-enhancing glucan

 #184
20060020128
2006-01-26

Therapy-enhancing glucan

 #185
20060002969
2006-01-05

Methods for reducing the foreign body reaction

 #186
20050191289
2005-09-01

Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption

 #187
20050176947
2005-08-11

Optical recording apparatus using one-dimensional diffractive light modulator

 #188
20050084495
2005-04-21

Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent

 #189
16383940
2020-10-13

Targeted nanoparticles

 #190
12324618
2016-02-16

Bioactive agent-loaded targeting micelles